Long-Term Study of COVID-19 Infection and Long COVID

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
University of North Carolina, Chapel Hill
Study ID
NCT07781501
Status
Recruiting

Conditions

  • SARS CoV-2 Post-Acute Sequelae

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • This study is observational. Only patients who have previously tested positive for SARS-CoV-2 infection or are experiencing ongoing symptoms. — OTHER
    Other:

Study Details

This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect information about participants' health and symptoms through questionnaires and may collect saliva and other non-invasive oral samples. The study will also examine biological factors in these samples that may be associated with persistent symptoms. The goal is to better understand why some people develop Long COVID and identify factors that may help predict who is more likely to experience persistent symptoms.

Key Dates

First listed
Aug 24, 2026
Start date
Sep 4, 2024
Status verified
Aug 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2029

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: COVID-19+
    Adults who have previously had COVID-19 and may be experiencing ongoing symptoms or changes in their health following infection.

Primary Outcome Measure

Salivary Proteomic Profile [ Time Frame: During active infection through three months post infection ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of North CarolinaChapel HillNorth Carolina27599-7555
Laura A Jacox, PhD, DMD, MS
+1 847-702-0988
Jeannene L Matthews, MA, M.Ed., CCC-SLP
+1 919-537-5999
Laura A Jacox, PhD, DMD, MS (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chapel Hill, NC

Related Studies